Literature DB >> 25724039

Sudden cardiac death: a modern pathology approach to hypertrophic cardiomyopathy.

Linda Kocovski1, John Fernandes.   

Abstract

Hypertrophic cardiomyopathy is one of the most common causes of sudden cardiac death among young adults and adolescents. Unfortunately, the first manifestation of the condition may be sudden death during exertion, such as sporting activities. Other clinical symptoms include exertional dyspnea, angina, and syncope. Postmortem examination often reveals asymmetrical septal thickening and mural plaque formation in the left ventricular outflow tract. Histologic analysis shows cardiac myocyte hypertrophy, myofiber disarray, and interstitial and replacement fibrosis. Molecular analysis for known genetic abnormalities is essential to genetic counseling of living relatives of decedents to assess and reduce the risk of sudden cardiac death from hypertrophic cardiomyopathy.

Entities:  

Mesh:

Year:  2015        PMID: 25724039     DOI: 10.5858/arpa.2013-0489-RS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  3 in total

Review 1.  Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy.

Authors:  Richard J Marszalek; R John Solaro; Beata M Wolska
Journal:  Pflugers Arch       Date:  2018-10-29       Impact factor: 3.657

Review 2.  Anatomical-MRI Correlations in Adults and Children with Hypertrophic Cardiomyopathy.

Authors:  Radu Ovidiu Rosu; Ana Lupsor; Alexandru Necula; Gabriel Cismaru; Simona Sorana Cainap; Daniela Iacob; Cecilia Lazea; Andrei Cismaru; Alina Gabriela Negru; Dana Pop; Gabriel Gusetu
Journal:  Diagnostics (Basel)       Date:  2022-02-14

3.  Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.

Authors:  Xin Huang; Yan Yue; Yinmeng Wang; Yujiao Deng; Lu Liu; Yanqi Di; Shasha Sun; Deyou Chen; Li Fan; Jian Cao
Journal:  Cardiovasc Ultrasound       Date:  2018-10-02       Impact factor: 2.062

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.